Received Nov 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Muscle ache; Tiredness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle ache) and tiredness (Verbatim: Tiredness). The outcome of the muscle pain and tiredness were not reported. It was unknown if the reporter considered the muscle pain and tiredness to be related to Shingrix. It was unknown if the company considered the muscle pain and tiredness to be related to Shingrix. Additional Information: GSK receipt date: 18-NOV-2025 The reporter asked how long muscle ache and tiredness last after the second dose. The batch number was not provided, and we were unable to contact the reporter.